Trials / Completed
CompletedNCT00545844
Singulair(R) In Asthma And Allergic Rhinitis (0476-383)
An 8 Week Study to Evaluate the Effectiveness of Adding Montelukast to Inhaled Corticosteroid (ICS) to the ICS/Long-Acting Beta 2-Agonist Therapy in Adult Subjects With Asthma and Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 313 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
Effectiveness of adding montelukast to inhaled corticosteroids in adult subjects with both uncontrolled asthma and allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | montelukast sodium | montelukast sodium, 10 mg, one tablet once a day for 8 weeks as add on therapy to usual current asthma controller treatment |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2008-01-01
- Completion
- 2008-01-01
- First posted
- 2007-10-17
- Last updated
- 2024-05-23
- Results posted
- 2009-08-19
Source: ClinicalTrials.gov record NCT00545844. Inclusion in this directory is not an endorsement.